Cargando…
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We exa...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658916/ https://www.ncbi.nlm.nih.gov/pubmed/33194646 http://dx.doi.org/10.3389/fonc.2020.566822 |
_version_ | 1783608748730744832 |
---|---|
author | Carta, Roberto Del Baldo, Giada Miele, Evelina Po, Agnese Besharat, Zein Mersini Nazio, Francesca Colafati, Giovanna Stefania Piccirilli, Eleonora Agolini, Emanuele Rinelli, Martina Lodi, Mariachiara Cacchione, Antonella Carai, Andrea Boccuto, Luigi Ferretti, Elisabetta Locatelli, Franco Mastronuzzi, Angela |
author_facet | Carta, Roberto Del Baldo, Giada Miele, Evelina Po, Agnese Besharat, Zein Mersini Nazio, Francesca Colafati, Giovanna Stefania Piccirilli, Eleonora Agolini, Emanuele Rinelli, Martina Lodi, Mariachiara Cacchione, Antonella Carai, Andrea Boccuto, Luigi Ferretti, Elisabetta Locatelli, Franco Mastronuzzi, Angela |
author_sort | Carta, Roberto |
collection | PubMed |
description | Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes. |
format | Online Article Text |
id | pubmed-7658916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76589162020-11-13 Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era Carta, Roberto Del Baldo, Giada Miele, Evelina Po, Agnese Besharat, Zein Mersini Nazio, Francesca Colafati, Giovanna Stefania Piccirilli, Eleonora Agolini, Emanuele Rinelli, Martina Lodi, Mariachiara Cacchione, Antonella Carai, Andrea Boccuto, Luigi Ferretti, Elisabetta Locatelli, Franco Mastronuzzi, Angela Front Oncol Oncology Medulloblastoma is the most common malignant brain tumor in children. In addition to sporadic cases, medulloblastoma may occur in association with cancer predisposition syndromes. This review aims to provide a complete description of inherited cancer syndromes associated with medulloblastoma. We examine their epidemiological, clinical, genetic, and diagnostic features and therapeutic approaches, including their correlation with medulloblastoma. Furthermore, according to the most recent molecular advances, we describe the association between the various molecular subgroups of medulloblastoma and each cancer predisposition syndrome. Knowledge of the aforementioned conditions can guide pediatric oncologists in performing adequate cancer surveillance. This will allow clinicians to promptly diagnose and treat medulloblastoma in syndromic children, forming a team with all specialists necessary for the correct management of the other various manifestations/symptoms related to the inherited cancer syndromes. Frontiers Media S.A. 2020-10-29 /pmc/articles/PMC7658916/ /pubmed/33194646 http://dx.doi.org/10.3389/fonc.2020.566822 Text en Copyright © 2020 Carta, Del Baldo, Miele, Po, Besharat, Nazio, Colafati, Piccirilli, Agolini, Rinelli, Lodi, Cacchione, Carai, Boccuto, Ferretti, Locatelli and Mastronuzzi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Carta, Roberto Del Baldo, Giada Miele, Evelina Po, Agnese Besharat, Zein Mersini Nazio, Francesca Colafati, Giovanna Stefania Piccirilli, Eleonora Agolini, Emanuele Rinelli, Martina Lodi, Mariachiara Cacchione, Antonella Carai, Andrea Boccuto, Luigi Ferretti, Elisabetta Locatelli, Franco Mastronuzzi, Angela Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title | Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title_full | Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title_fullStr | Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title_full_unstemmed | Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title_short | Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era |
title_sort | cancer predisposition syndromes and medulloblastoma in the molecular era |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658916/ https://www.ncbi.nlm.nih.gov/pubmed/33194646 http://dx.doi.org/10.3389/fonc.2020.566822 |
work_keys_str_mv | AT cartaroberto cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT delbaldogiada cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT mieleevelina cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT poagnese cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT besharatzeinmersini cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT naziofrancesca cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT colafatigiovannastefania cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT piccirillieleonora cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT agoliniemanuele cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT rinellimartina cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT lodimariachiara cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT cacchioneantonella cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT caraiandrea cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT boccutoluigi cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT ferrettielisabetta cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT locatellifranco cancerpredispositionsyndromesandmedulloblastomainthemolecularera AT mastronuzziangela cancerpredispositionsyndromesandmedulloblastomainthemolecularera |